This Project Grant award of $398,587 from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) supports research to examine Medicare Advantage (MA) plan enrollment patterns and effects on utilization and outcomes for dual eligible Medicare and Medicaid beneficiaries.
The multi-year study, conducted by the Massachusetts General Hospital Research Management Division, will analyze longitudinal enrollment data to...
This Project Grant award of $2,297,026 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to study the effects of "long-term care integration" models, such as Dual-Eligible Special Needs Plans (D-SNPs), on health outcomes for dually eligible individuals with Alzheimer's disease and related dementias (ADRD). The award will leverage Medicare and Medicaid claims data from 2018-2024 to evaluate the causal impacts of...
This $2,112,538 Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), will fund research to compare the effectiveness of integrated Dual Eligible Special Needs Plans (D-SNPs) versus non-integrated D-SNPs in improving health care access, quality, and outcomes for individuals with dementia. The grant will leverage nationwide linked Medicare-Medicaid administrative data from 2021-2023 to conduct three key analyses: 1)...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD).
The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This federal Project Grant award, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), supports research to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services introduced by the Centers for Medicare & Medicaid Services. The $794,956 award to the Hebrew Rehabilitation Center (doing business as Hebrew Senior Life) aims to determine the impact of these services on home time, survival, and...
This federal Project Grant award, funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), is intended to examine ways to align the incentives created by the Medicare and Medicaid programs in nursing homes to improve care for residents with Alzheimer's disease and related dementias (AD/ADRD).
The $2,210,409 award, granted to the Trustees of the University of Pennsylvania (doing business as the Clinical Practices of the University of Pennsylvania), aims...
This $2,010,044 federal Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) will assess the impact of Institutional Special Needs Plan (I-SNP) enrollment on quality of long-term and end-of-life care for elderly nursing home residents with Alzheimer's disease and related dementias (ADRD). The study will use a mixed-methods approach, including quasi-experimental econometric analyses on Medicare claims and health record data, as well as...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $640,128 to the University of Colorado-Denver to study the impacts of Medicare coverage choice on healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The key research objectives are to: 1) Compare ADRD patient outcomes like potentially preventable hospitalizations in Medicare Advantage (MA) versus...
This $2,124,788 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to assess the impact of the new Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) program on outcomes and equity for Medicare beneficiaries with Alzheimer's disease and related dementias.
The project aims to: 1) Compare REACH ACOs to the existing Medicare Shared Savings Program (MSSP) ACOs and non-participants to determine if REACH is...
This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), will fund a research study titled "The Effects of Changing Health Care Markets on Cardiovascular and Cerebrovascular Care and Outcomes". The total award amount is $774,972 with a project period from September 15, 2024 to August 31, 2029.
The study aims to quantify the effects of changes in the healthcare market, such as hospital mergers/acquisitions and openings/closures, on...
This $2,283,522 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to evaluate the impact of a Centers for Medicare & Medicaid Services (CMS) policy on improving integrated care and health outcomes for Medicare-Medicaid dual eligible beneficiaries.
Specifically, the study will examine the effects of CMS' "80% rule" that stopped renewing contracts with Medicare Advantage plans where 80% or more of enrollees are dual eligibles. The research will assess how this policy impacts enrollment in Integrated Care Plans, which coordinate Medicare and Medicaid services, as well as the effects on quality of care, clinical outcomes, and utilization of low-value or potentially avoidable care among dual eligible beneficiaries. The project will focus on evaluating impacts for high-risk subpopulations including those with dementia, frailty, mental illness, and from historically marginalized groups. Harvard T.H. Chan School of Public Health will serve as the prime grantee, collaborating with Brigham & Women's Hospital and the University of Pennsylvania as subrecipients to provide statistical and econometric expertise.